C
C. Burch
Researcher at University of California, Los Angeles
Publications - 9
Citations - 584
C. Burch is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Heart transplantation & Transplantation. The author has an hindex of 7, co-authored 9 publications receiving 567 citations.
Papers
More filters
Journal ArticleDOI
Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease.
Paul J Michaels,Maria L. Espejo,Jon A. Kobashigawa,Juan C. Alejos,C. Burch,Takemoto S,Elaine F. Reed,Michael C. Fishbein +7 more
TL;DR: Humoral rejection is a clinicopathologic entity with a high incidence in women and is associated with acute hemodynamic compromise, accelerated transplant coronary artery disease and death.
Journal ArticleDOI
Use of assist devices and ECMO to bridge pediatric patients with cardiomyopathy to transplantation.
Daniel S. Levi,Daniel Marelli,Mark Plunkett,Juan C. Alejos,Jessica Bresson,Julie Tran,Christian Eisenring,Sadeghi Am,Alvaro Galindo,Daniel Fazio,Anuja Gupta,C. Burch,Barbara L. George,Hillel Laks +13 more
TL;DR: Pulsatile and continuous-flow devices can complement each other to significantly extend the lives of a wide range of pediatric patients with severe cardiomyopathies.
Journal ArticleDOI
B-type natriuretic peptide in children after cardiac transplantation.
TL;DR: Although BNP concentration relative to time after OHT varied among individuals, all patients with multiple measurements showed predictable rates of decrease, and the decrease was not associated with changes in LVEDD.
Journal ArticleDOI
The yield of surveillance endomyocardial biopsies as a screen for cellular rejection in pediatric heart transplant patients
TL;DR: For pediatric patients more than 30’days after OHT, EMB has failed to reveal significant episodes of cellular rejection in asymptomatic patients managed with tacrolimus.
Journal ArticleDOI
Use of OKT3 for Acute Myocarditis in Infants and Children
Joseph Ahdoot,Alvaro Galindo,Juan C. Alejos,Barbara L. George,C. Burch,Daniel Marelli,Sadeghi Am,Hillel Laks +7 more
TL;DR: In patients with severe acute myocarditis, aggressive immunosuppressive regimen based on OKT3 is safe and may inhibit or reverse the immune response, resulting in dramatic improvement in myocardial function.